The mechanism of protein synthesis and its regulation in the cell determines the diversity and capacity of the proteome. The central integration point for this regulatory control is the ribosome: a two-subunit, megadalton RNA-protein assembly. Highlighting the exquisite sensitivity of translation and the ribosome to regulation, the majority of known antibiotics either dysregulate or block ribosome function. Correspondingly, delineation of the protein synthesis mechanism in molecular detail has the potential to inform on paradigms of gene expression control and on how to combat the global health threat of emerging and drug resistant pathogens. As the loss of translation control is a hallmark of cancer, a deeper understanding of the protein synthesis mechanism also holds the promise of targeted therapeutic strategies for human disease treatments that are currently lacking. Investigations into structure-function relationships governing the translation mechanism have been principally conducted in bacteria using traditional ensemble methods. Such studies have revealed that the phase of translation in which protein is synthesized from messenger RNA (mRNA), termed elongation, is the most time intensive and commonly drug-targeted. They have also discerned that elongation entails the ribosome transiently interacting with specific cellular components through an ordered series of events, where the decoding of each mRNA codon is accompanied by large-scale conformational changes within the ribosome and interacting factors, and between the ribosome and its mRNA and transfer RNA (tRNA) substrates. The need for large amounts of homogenous material has thwarted analogous investigations of the human translation mechanism. Hence, conserved and divergent features of the translation mechanism between single-cell organisms and mammals that determine the molecular basis of antibiotic specificity have remained largely obscure. Here, we seek to delineate common and distinct features of bacterial and human protein synthesis ? and the translation mechanisms in healthy and cancerous human cells ? to: 1] improve the efficacies of existing antibiotics; 2] develop new strategies for antibiotic interventions; and 3] explore the possibility of therapies targeting unchecked proliferative cell growth and metastatic spread. We will do so by establishing quantitative, structural and kinetic frameworks for the elemental steps of elongation in bacteria and humans using an integrated battery of biophysical methods, including single-molecule fluorescence imaging and state-of-the-art cryo-electron microscopy. Our collaborative investigations will delineate the order and timing of conformational events underpinning fidelity in bacterial and human elongation cycles and the structural and mechanistic distinctions that determine the efficacies of clinically relevant antibiotics targeting these processes. These insights will shed light on how translation control is achieved, reveal atomic-resolution descriptions drug action on bacterial and human ribosomes and inform opportunities for new interventions aimed at improving the efficacy and potency of clinical treatments for infectious pathogens and human disease.

Public Health Relevance

Protein synthesis regulation is a central point of gene expression control and targeting this process with small molecules has been a proven line of defense for the treatment of infectious disease for nearly a century. Unfortunately, incomplete knowledge of the protein synthesis mechanism has hampered progress towards delineating the molecular basis of regulation ? and thus the design of novel translation-targeting agents ? while the threat of antibiotic resistance is increasing. Through an integrated battery of quantitative biophysical and structural investigations, we seek to define complete kinetic mechanisms of bacterial and human protein synthesis reactions to gain critical new insights into the molecular origins of antibiotic action and specificity that can be used to inform clinical strategies for combating infectious pathogens and for treating human disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM079238-15
Application #
10072525
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Flicker, Paula F
Project Start
2006-09-15
Project End
2024-07-31
Budget Start
2020-09-15
Budget End
2021-07-31
Support Year
15
Fiscal Year
2020
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Flis, Julia; Holm, Mikael; Rundlet, Emily J et al. (2018) tRNA Translocation by the Eukaryotic 80S Ribosome and the Impact of GTP Hydrolysis. Cell Rep 25:2676-2688.e7
Blanchard, Scott C (2018) A Much-Needed Boost for the Dwindling Antibiotic Pipeline. Mol Cell 70:3-5
Kurylo, Chad M; Parks, Matthew M; Juette, Manuel F et al. (2018) Endogenous rRNA Sequence Variation Can Regulate Stress Response Gene Expression and Phenotype. Cell Rep 25:236-248.e6
Parks, Matthew M; Kurylo, Chad M; Dass, Randall A et al. (2018) Variant ribosomal RNA alleles are conserved and exhibit tissue-specific expression. Sci Adv 4:eaao0665
Prokhorova, Irina; Altman, Roger B; Djumagulov, Muminjon et al. (2017) Aminoglycoside interactions and impacts on the eukaryotic ribosome. Proc Natl Acad Sci U S A 114:E10899-E10908
Alejo, Jose L; Blanchard, Scott C (2017) Miscoding-induced stalling of substrate translocation on the bacterial ribosome. Proc Natl Acad Sci U S A 114:E8603-E8610
Juette, Manuel F; Terry, Daniel S; Wasserman, Michael R et al. (2016) Single-molecule imaging of non-equilibrium molecular ensembles on the millisecond timescale. Nat Methods 13:341-4
Kurylo, Chad M; Alexander, Noah; Dass, Randall A et al. (2016) Genome Sequence and Analysis of Escherichia coli MRE600, a Colicinogenic, Nonmotile Strain that Lacks RNase I and the Type I Methyltransferase, EcoKI. Genome Biol Evol 8:742-52
Arenz, Stefan; Juette, Manuel F; Graf, Michael et al. (2016) Structures of the orthosomycin antibiotics avilamycin and evernimicin in complex with the bacterial 70S ribosome. Proc Natl Acad Sci U S A 113:7527-32
Cocozaki, Alexis I; Altman, Roger B; Huang, Jian et al. (2016) Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors. Proc Natl Acad Sci U S A 113:8188-93

Showing the most recent 10 out of 49 publications